Lv54
1560 积分 2024-07-09 加入
MG-K10, a Long-Acting Anti-IL-4 Receptor Alpha Monoclonal Antibody in Adult Patients with Moderate-to-Severe Atopic Dermatitis
13天前
已完结
MG-K10, a Long-Acting Anti-IL-4 Receptor Alpha Monoclonal Antibody in Adult Patients with Moderate-to-Severe Atopic Dermatitis
13天前
已关闭
Tezepelumab in Adults with Severe Chronic Rhinosinusitis with Nasal Polyps
1个月前
已完结
Efficacy and Safety of Pumecitinib Gel for Treating Mild-to-moderate Atopic Dermatitis: a Multicentre, Randomised, Double-blind, Parallel, Placebo-controlled Phase IIb Clinical Trial
1个月前
已完结
Strategies for composite estimands in confirmatory clinical trials: Examples from trials in nasal polyps and steroid reduction
2个月前
已完结
Missing data in clinical trials: control‐based mean imputation and sensitivity analysis
2个月前
已完结
Tezepelumab in Adults with Severe Chronic Rhinosinusitis with Nasal Polyps
2个月前
已关闭
Tezepelumab in Adults with Severe Chronic Rhinosinusitis with Nasal Polyps
2个月前
已完结
Efficacy and Safety of GR1802 in Patients With Moderate‐to‐Severe Atopic Dermatitis: A Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Phase 2 Trial
3个月前
已关闭
Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial
3个月前
已完结
皖公网安备34019202002308
